Click to copy
Click to copy

Corcept: 3Q Earnings Snapshot

November 1, 2018

MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported third-quarter profit of $17.8 million.

The Menlo Park, California-based company said it had net income of 14 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were 22 cents per share.

The drug developer posted revenue of $64.4 million in the period.

Corcept expects full-year revenue in the range of $250 million to $270 million.

Corcept shares have dropped 32 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $12.23, a decrease of 36 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT

All contents © copyright 2019 The Associated Press. All rights reserved.